PLRZ
$14.45+0.16 (+1.12%)
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a r...
Recent News
This Former Penny Stock Just Doubled for the Second Time This Week. Should You Chase the Rally Here?
Polyrizon shares have skyrocketed this week on breakthrough preclinical data for its naloxone hydrogen. But PLRZ stock remains a risky proposition heading into 2026.
We Think Polyrizon (NASDAQ:PLRZ) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
BC-Most Active Stocks
HIVE Digital Technologies Ltd. 15,939,276 3.3797
Top Midday Gainers
Smart Digital Group (SDM) said late Thursday that it priced its initial public offering of 1.5 milli
Psychedelic: atai Life Sciences, NRx report quarterly results
In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on earnings, a collaboration LOI and a study publication. EARNINGS: On Monday, atai Life Sciences (ATAI) reported a fourth quarter loss per share of (24c) on revenue loss of ($5,000), which compared to analyst estimates of a loss per share of (15c) and revenue of $18,000 for the same period last year. As of December 31, the company had cash, cash equivalents, restricted cash and short-t